北京大学学报(医学版) ›› 2020, Vol. 52 ›› Issue (6): 991-994. doi: 10.19723/j.issn.1671-167X.2020.06.001
• 专家笔谈 • 下一篇
摘要:
中图分类号:
| [1] |
Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic Syndrome[J]. Lancet, 2014,383(9927):1503-1516.
doi: 10.1016/S0140-6736(13)61048-X pmid: 24290661 |
| [2] |
黄文秋, 王旖旎, 王晶石, 等. 192例成人噬血细胞淋巴组织细胞增生症患者的临床分析[J]. 中华血液学杂志, 2014,35(9):796-801.
doi: 10.3760/cma.j.issn.0253-2727.2014.09.003 |
| [3] |
Atteritano M, David A, Bagnato G, et al. Haemophagocytic syndrome in rheumatic patients. A systematic review[J]. Eur Rev Med Pharmacol Sci, 2012,16(10):1414-1424.
pmid: 23104659 |
| [4] |
Ahn SS, Yoo BW, Jung SM, et al. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classificationcriteria for macrophage activation syndrome[J]. Semin Arthritis Rheum, 2017,47(2):216-221.
doi: 10.1016/j.semarthrit.2017.02.002 pmid: 28268026 |
| [5] |
Ravelli A, Minoia F, Davì S, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juve-nile idiopathic arthritis: A European League Against Rheumatism / American College of Rheumatology / Paediatric Rheumatology International Trials Organisation Collaborative Initiative[J]. Ann Rheum Dis, 2016,75(3):481-489.
pmid: 26865703 |
| [6] |
Ahn SS, Yoo BW, Jung SM, et al. Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease[J]. J Rheumatol, 2017,44(7):996-1003.
doi: 10.3899/jrheum.161286 pmid: 28412707 |
| [7] |
Liu AC, Yang Y, Li MT, et al. Macrophage activation syndrome in systemic lupus erythematosus: A multicenter, case-controlstudy in China[J]. Clin Rheumatol, 2018,37(1):93-100.
pmid: 28409239 |
| [8] |
Zhang M, Behrens EM, Atkinson TP, et al. Genetic defects in cytolysis in macrophage activation syndrome[J]. Curr Rheumatol Rep, 2014,16(9):439.
doi: 10.1007/s11926-014-0439-2 pmid: 25086802 |
| [9] |
Wang Y, Wang Z, Zhang J, et al. Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood[J]. PLoS One, 2014,9(9):e107386.
doi: 10.1371/journal.pone.0107386 pmid: 25233452 |
| [10] |
Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007,48(2):124-131.
doi: 10.1002/pbc.21039 pmid: 16937360 |
| [11] |
Davì S, Minoia F, Pistorio A, et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis[J]. Arthritis Rheumatol, 2014,66(10):2871-2880.
doi: 10.1002/art.38769 pmid: 25044674 |
| [12] |
Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juve-nile idiopathic arthritis[J]. J Pediatr, 2005,146(5):598-604.
doi: 10.1016/j.jpeds.2004.12.016 pmid: 15870661 |
| [13] |
La Rosee P, Horne A, Hines M, et al. Recommendations of the management of hemophagocytic lymphohistiocytosis in adults[J]. Blood, 2019,133(23):2465-2477.
doi: 10.1182/blood.2018894618 pmid: 30992265 |
| [14] |
Tada Y, Inokuchi S, Maruyama A, et al. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still’s disease?[J]. Rheumatol Int, 2019,39(1):97-104.
doi: 10.1007/s00296-018-4114-1 pmid: 30051293 |
| [15] |
Minoia F, Bovis F, Davì S, et al. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis[J]. Ann Rheum Dis, 2019,78(10):1357-1362.
doi: 10.1136/annrheumdis-2019-215211 pmid: 31296501 |
| [16] | Wang R, Li T, Ye S, et al. Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease [J/OL]. Ann Rheum Dis, (2019-10-14) [2020-06-25]. doi: 10.1136/annrheumdis-2019-216286. |
| [17] | 姚海红, 王旖旎, 张霞, 等. 67例成人巨噬细胞活化综合征的临床特征及治疗转归[J]. 北京大学学报(医学版), 2019,51(6):996-1002. |
| [18] |
Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy[J]. Nat Rev Rheumatol, 2016,12(5):259-268.
doi: 10.1038/nrrheum.2015.179 pmid: 27009539 |
| [19] |
Weiss ES, Girard-Guyonvarc’h C, Holzinger D, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome[J]. Blood, 2018,131(13):1442-1455.
doi: 10.1182/blood-2017-12-820852 pmid: 29326099 |
| [1] | 季加孚, 韦静涛, 季科, 步召德. 胃癌诊疗的瓶颈与破局:迈向精准化与智能化融合的新纪元[J]. 北京大学学报(医学版), 2026, 58(2): 231-238. |
| [2] | 王海, 江一舟. 靶向血管治疗在乳腺癌精准治疗中的分子机制与临床应用[J]. 北京大学学报(医学版), 2026, 58(2): 251-256. |
| [3] | 付浩, 申潞艳, 黄冰洋, 马少华. 免疫治疗背景下食管鳞状细胞癌围手术期治疗的临床思考[J]. 北京大学学报(医学版), 2026, 58(2): 266-271. |
| [4] | 刘友东, 吕亚军, 陈杰, 臧明德, 潘宏达, 刘晓文, 陆俊, 刘凤林. 全腹腔镜保留贲门胃底胃次全切除术治疗中上部胃癌的疗效及安全性[J]. 北京大学学报(医学版), 2026, 58(2): 301-306. |
| [5] | 李伟浩, 张学民, 李伟, 张韬, 张小明. 胸主动脉腔内修复术左肱动脉穿刺点使用血管缝合器处理的临床效果[J]. 北京大学学报(医学版), 2026, 58(2): 388-392. |
| [6] | 李嘉临, 陈力侨, 唐家天, 吴艳, 王安强. 胃肝样腺癌转化治疗1例[J]. 北京大学学报(医学版), 2026, 58(2): 399-404. |
| [7] | FarinEbrahimi, 冯志强, FarazEbrahimi, 韩玮华, 于子杨, 贾宽宽, 安金刚. 上颌药物相关性颌骨坏死的不同分期手术治疗效果[J]. 北京大学学报(医学版), 2026, 58(1): 107-114. |
| [8] | 赵业, 刁小莉, 熊焰. 细胞转移技术在微量细胞液病理诊断中的应用[J]. 北京大学学报(医学版), 2026, 58(1): 208-213. |
| [9] | 臧海玲, 梁宇红. 上颌第二磨牙慢性根尖周炎合并器械分离的根管再治疗1例[J]. 北京大学学报(医学版), 2026, 58(1): 214-219. |
| [10] | 王月, 梁宇红. 繁茂型牙骨质-骨结构不良1例[J]. 北京大学学报(医学版), 2026, 58(1): 220-224. |
| [11] | 潘莲菲, 李文静, 王瑞洋, 焦剑, 曹战强, 高丽, 释栋. 口服抗生素辅助牙周机械治疗对重度牙周炎的短期疗效及影响因素[J]. 北京大学学报(医学版), 2026, 58(1): 30-36. |
| [12] | 池彦廷, 蒋鸿杰, 陈艳, 徐志秀, 李斌斌. 直接免疫荧光在口腔黏膜寻常型天疱疮诊断中的价值: 基于多指标联合分析的回顾性研究[J]. 北京大学学报(医学版), 2026, 58(1): 68-73. |
| [13] | 顾静妍, 李欣艺, 赵金霞, 穆荣. 误诊为类风湿关节炎、痛风的糖尿病致Charcot关节病1例[J]. 北京大学学报(医学版), 2025, 57(6): 1193-1197. |
| [14] | 肖晓笛, 夏有辰, 柳剑英, 付鹏. 左侧胸锁乳突肌间血管内乳头状内皮增生1例[J]. 北京大学学报(医学版), 2025, 57(5): 1002-1004. |
| [15] | 谢尚, 王鹿鸣, 张馨元, 冯秋实, 夏洋洋, 戴姿薇, 单小峰, 蔡志刚. 口腔鳞癌类器官库的构建及应用[J]. 北京大学学报(医学版), 2025, 57(5): 847-851. |
|
||